Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Revenue (2016 - 2020)

Edesa Biotech's Revenue history spans 8 years, with the latest figure at $500.0 for Q3 2020.

  • For Q3 2020, Revenue changed N/A year-over-year to $500.0; the TTM value through Jun 2021 reached $500.0, down 99.85%, while the annual FY2020 figure was $328801.0, N/A changed from the prior year.
  • Revenue for Q3 2020 was $500.0 at Edesa Biotech, down from $109985.0 in the prior quarter.
  • Across five years, Revenue topped out at $326335.0 in Q1 2016 and bottomed at -$931587.0 in Q3 2016.
  • The 5-year median for Revenue is $20532.0 (2017), against an average of $691.67.
  • The largest annual shift saw Revenue crashed 16579.52% in 2016 before it surged 21897.0% in 2020.
  • A 5-year view of Revenue shows it stood at $141856.0 in 2016, then tumbled by 85.56% to $20487.0 in 2017, then plummeted by 869.23% to -$157592.0 in 2018, then skyrocketed by 168.4% to $107800.0 in 2019, then tumbled by 99.54% to $500.0 in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Revenue are $500.0 (Q3 2020), $109985.0 (Q2 2020), and $110516.0 (Q1 2020).